Inovalon Agrees to Acquire DrFirst for Medication Management

An EHR vendor can use DrFirst to bring pharmacy and benefit information into prescribing while keeping control of the screen its customers already know. That arrangement helps explain what Inovalon would gain from buying the company: a place for healthcare intelligence inside a relationship another software provider has already earned.

The companies announced a definitive acquisition agreement on November 11, 2026. Inovalon wants to connect its data and analytics with DrFirst's prescribing, prior authorization, benefit determination and patient communications capabilities. The agreement is subject to required regulatory approvals and customary closing conditions; the announcement leaves financial terms and the expected closing date undisclosed.

For healthcare operators, the transaction raises a practical product question. Information about a medication becomes more useful when it arrives while somebody can still change the prescription, resolve a coverage issue or help the patient understand the next step. Inovalon's proposed expansion reaches further into that work, where the value of a dataset depends partly on its route into a clinical decision.

The interface is part of the acquisition logic

DrFirst's Gadget prescription-orchestration offering is built around the EHR vendor's existing experience. DrFirst describes an intelligence layer that brings pharmacy dispensing rules and benefit information into prescribing, with the vendor controlling what information appears, when it appears and how it looks. Its product proposition includes surfacing information when action is required rather than sending the clinician into another application.

That gives the EHR company an important role in the commercial relationship. It can offer additional capabilities while retaining the interface through which its customers encounter them. For Inovalon, acquiring the supplier behind that arrangement would bring a distribution relationship alongside medication technology. The analysis rests on how the product is designed, rather than an assumption that acquiring a company automatically changes every customer's workflow.

A prescription returned for clarification creates another assignment for the practice. Earlier access to relevant dispensing and benefit details could move some of that work into the original order, which is the opportunity DrFirst describes. The operating questions then become specific: which information is available, who can act on it and how the workflow handles an exception. Those details will matter to customers evaluating any broader offering after the transaction.

Two histories meet inside medication management

James F. Chen founded DrFirst in 2000 and is now its executive chairman. The company's development spans prescribing, medication history, price transparency and patient engagement. Current CEO Laizer Kornwasser brings experience across telemedicine, pharmacy and pharmacy benefit management, a background relevant to the different institutions that can participate in a prescription.

DrFirst's financing history also provides a useful measure of the time spent building the business. A May 2021 company announcement recorded a $50M follow-on equity investment from Sixth Street Growth, following $35M from Sixth Street and $50M from Goldman Sachs Growth in 2020. The disclosed $135M total covers that 2020-21 period; it is separate from the acquisition's undisclosed consideration.

Inovalon's history begins in 1998 and includes expansion through acquisitions such as ABILITY Network in 2018 and VigiLanz in 2024. Nordic Capital led the consortium that took Inovalon private in 2021, and remains identified as its lead investor in the DrFirst announcement. Under CEO Adam Kansler, the proposed purchase would add another set of clinical relationships to a business serving payers, providers, pharmacies and life sciences organizations.

These histories make the transaction more substantial than a new feature attached to an analytics platform. DrFirst brings a company built around medication tasks and the organizations already relying on them. Inovalon's opportunity is to make its broader information resources useful within those relationships, while accommodating the product expectations that helped establish them.

A larger offering still has several customers to serve

The joint announcement on DrFirst's site says the combined businesses would serve more than 2,000 hospitals and 240,000 prescribing providers across over 270 EHR integrations. Those are company-reported footprint figures. They describe reach across different customer and integration relationships, rather than one uniform deployment of a combined product.

An EHR vendor evaluating new functionality will care about development effort, control of its customer experience and the relevance of the information supplied. A prescribing practice will care about whether an order moves forward with less administrative follow-up. A pharmacy encounters its own dispensing requirements, while a patient needs to understand access, cost and the steps required to start therapy. Connecting these interests is the commercial opportunity described by the deal.

For that reason, customers have grounds to ask for concrete implementation detail as the proposed combination develops. The announcement provides no migration timetable, revised contract terms or post-close product schedule. An organization already using either company's software can use its existing vendor relationship to establish how its particular service will be supported, rather than infer an operational change from the acquisition headline.

DevCuration's coverage of Ellipsis Health's acquisition of Kouper examines a related healthcare software question: how information connects to the work needed to arrange care. The medication story has its own participants and obligations. For Inovalon and DrFirst, the next product conversation will have to account for the EHR vendor retaining its interface, the clinician making a treatment decision and the pharmacy receiving the order that follows.